- Home
- ZAPP vs VIVS Comparison
ZAPP vs VIVS Comparison
Compare ZAPP & VIVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZAPP
- VIVS
- Stock Information
- Founded
- ZAPP 2017
- VIVS 2007
- Country
- ZAPP Thailand
- VIVS United States
- Employees
- ZAPP N/A
- VIVS N/A
- Industry
- ZAPP Motor Vehicles
- VIVS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ZAPP Consumer Discretionary
- VIVS Health Care
- Exchange
- ZAPP Nasdaq
- VIVS Nasdaq
- Market Cap
- ZAPP 3.7M
- VIVS 3.1M
- IPO Year
- ZAPP N/A
- VIVS N/A
- Fundamental
- Price
- ZAPP $0.29
- VIVS $2.07
- Analyst Decision
- ZAPP
- VIVS
- Analyst Count
- ZAPP 0
- VIVS 0
- Target Price
- ZAPP N/A
- VIVS N/A
- AVG Volume (30 Days)
- ZAPP 8.9M
- VIVS 387.4K
- Earning Date
- ZAPP 06-20-2025
- VIVS 05-30-2025
- Dividend Yield
- ZAPP N/A
- VIVS N/A
- EPS Growth
- ZAPP N/A
- VIVS N/A
- EPS
- ZAPP N/A
- VIVS N/A
- Revenue
- ZAPP $17,440.00
- VIVS $122,000.00
- Revenue This Year
- ZAPP $67,159.17
- VIVS $59.08
- Revenue Next Year
- ZAPP $1,149.53
- VIVS $18.24
- P/E Ratio
- ZAPP N/A
- VIVS N/A
- Revenue Growth
- ZAPP N/A
- VIVS N/A
- 52 Week Low
- ZAPP $0.28
- VIVS $1.56
- 52 Week High
- ZAPP $19.10
- VIVS $21.96
- Technical
- Relative Strength Index (RSI)
- ZAPP 29.22
- VIVS N/A
- Support Level
- ZAPP $0.26
- VIVS N/A
- Resistance Level
- ZAPP $0.93
- VIVS N/A
- Average True Range (ATR)
- ZAPP 0.09
- VIVS 0.00
- MACD
- ZAPP -0.01
- VIVS 0.00
- Stochastic Oscillator
- ZAPP 4.22
- VIVS 0.00
About ZAPP Zapp Electric Vehicles Group Limited
Zapp Electric Vehicles Group Ltd designs manufactures, and sells high-performance electric vehicles, including maintenance and repair of electric vehicles and related parts and accessories. Companies founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. The company operates in Cayman Islands, Europe, Thailand. Maximum of revenue is from Thailand.
About VIVS VivoSim Labs Inc. Common Stock
VivoSim Labs Inc formerly, Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.